Condition

Asthma, Allergic

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials20
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

20 shown
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive PollenNCT04891237 · 2021-06-14
RECRUITING
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.NCT04898283 · 2021-05-31
RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesNCT04435990 · 2020-10-06
RECRUITING
Plant Stanol Esters and Preventing Asthma SymptomsNCT03983603 · 2019-04-29
RECRUITING
Biologics and Sublingual ImmunotherapyNCT06027073 · 2024-05-01
NOT_YET_RECRUITING
Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic AsthmaNCT05740748 · 2023-04-01
UNKNOWN
Dupilumab Effects Against Aeroallergen ChallengeNCT05720325 · 2023-03-29
ACTIVE_NOT_RECRUITING
IL13 Signaling in Allergic AsthmaNCT05478824 · 2023-02-21
COMPLETED
Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.NCT05352126 · 2022-05-01
UNKNOWN
Effects of Low Dose Ozone on Airway Inflammatory Responses in Adults With Asthma - Sedentary Nasal Ozone (Asthma SNOZ)NCT04109807 · 2019-12-16
SUSPENDED
Anakinra as a Rescue Treatment for Allergic InflammationNCT04035109 · 2019-12-16
WITHDRAWN
Lung-Resident Memory Th2 Cells in AsthmaNCT03455959 · 2019-05-23
COMPLETED
Evaluating Asthma Exacerbation-induced Changes in Lung Function With a Home-based SpirometerNCT03705325 · 2019-02-22
COMPLETED
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.NCT03468790 · 2018-05-09
COMPLETED
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenNCT06063044 · 2018-01-01
COMPLETED
Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe AsthmaNCT03563521 · 2017-11-27
COMPLETED
Study of REGN3500 and Dupilumab in Patients With AsthmaNCT03112577 · 2017-06-15
COMPLETED
Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic RhinitisNCT02953106 · 2017-01-20
TERMINATED
ICS Treatment Compliance of Asthma PatientsNCT02990117 · 2016-11-01
COMPLETED
Validation of Proteomic Analyses for Allergic Asthma and RhinitisNCT01104012 · 2010-05-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED9
RECRUITING4
UNKNOWN2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
SUSPENDED1
TERMINATED1
WITHDRAWN1

Phase mix

NA5
PHASE34
PHASE23
PHASE12
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.